Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 13 Jul 23 424B3 Prospectus supplement
- 3 Jul 23 424B3 Prospectus supplement
- 7 Jun 23 EFFECT Notice of effectiveness
- 6 Jun 23 424B3 Prospectus supplement
- 2 Jun 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
27 Apr 23 S-4 Registration of securities issued in business combination transactions
MEIP similar filings
- 2 Jun 23 Registration of securities issued in business combination transactions (amended)
- 27 Apr 23 Registration of securities issued in business combination transactions
- 3 Mar 11 Registration of securities issued in business combination transactions (amended)
- 1 Feb 11 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 99.3
Consent of Person Named as About to Become Director
April 27, 2023
Pursuant to Rule 438 promulgated under the Securities Act of 1933, as amended, I hereby consent to my being named in the Registration Statement on Form S-4 MEI Pharma, Inc., and all amendments thereto (the “Registration Statement”), and any related prospectus filed pursuant to Rule 424 promulgated under the Securities Act of 1933, as amended, as a person anticipated to become a director of MEI Pharma, Inc. upon completion of the merger described therein, and to the filing of this consent as an exhibit to the Registration Statement.
Sincerely,
/s/ Adelene Q. Perkins
Name: Adelene Q. Perkins